LK
GILD icon

Lumbard & Kellner’s Gilead Sciences GILD Stock Holding History

Lumbard & Kellner’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$273K Hold
1,960
– – 0.09% 87
2025
Q4 		$241K Hold
1,960
– – 0.08% 94
2025
Q3 		$218K Hold
1,960
– – 0.08% 92
2025
Q2 		$217K Hold
1,960
– – 0.09% 85
2025
Q1 		$220K Buy
+1,960
New +$202K 0.1% 78
2017
Q2 		– Sell
-7,594
Closed -$516K – 88
2017
Q1 		$516K Buy
+7,594
New +$534K 0.31% 50

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Lumbard & Kellner's GILD Position: Q1 2026 in Review

Lumbard & Kellner held its Gilead Sciences (GILD) position steady in Q1 2026 at 1,960 shares worth $273K. The position accounts for 0.09% of the portfolio, ranked #87.

Lumbard & Kellner first reported a position in GILD in Q1 2017 and has held it in 6 quarters since. The position peaked at $516K in Q1 2017. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Lumbard & Kellner held 1,960 shares of Gilead Sciences worth $273K as of Q1 2026.
  • Lumbard & Kellner left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.09% of Lumbard & Kellner's portfolio in Q1 2026, its #87 holding.
  • Lumbard & Kellner first reported a position in Gilead Sciences in Q1 2017 and has held it in 6 quarters since.
  • Lumbard & Kellner's Gilead Sciences position peaked at $516K in Q1 2017.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Lumbard & Kellner's 13F filing for Q1 2026, filed 15 May 2026.